Details of the Drug Formulations

General Information of Drug (ID: DM4F29C)

Drug Name
Crizotinib Drug Info
Synonyms Xalkori (TN); novel ALK inhibitors
Indication
Disease Entry ICD 11 Status REF
Non-small-cell lung cancer 2C25.Y Approved [1]
Cross-matching ID
PubChem CID
11626560
ChEBI ID
CHEBI:64310
CAS Number
877399-52-5
TTD ID
D03ZBT
VARIDT ID
DR00523
INTEDE ID
DR0387
ACDINA ID
D00154

Full List of Drug Formulations Containing This Drug

Crizotinib 200 mg capsule
Company Formulation ID FDA Description
Pfizer Laboratories F05056 Magnesium stearate; Ammonia; Anhydrous dibasic calcium phosphate; Ferric oxide red; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Titanium dioxide; Silicon dioxide; Gelatin, unspecified; Microcrystalline cellulose; Shellac
------------------------------------------------------------------------------------
Crizotinib 250 mg capsule
Company Formulation ID FDA Description
Pfizer Laboratories F05057 Magnesium stearate; Ammonia; Anhydrous dibasic calcium phosphate; Ferric oxide red; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Titanium dioxide; Silicon dioxide; Gelatin, unspecified; Microcrystalline cellulose; Shellac
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4903).